nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—PPARG—Barrett's esophagus	0.482	0.703	CbGaD
Mesalazine—PTGS2—Barrett's esophagus	0.203	0.297	CbGaD
Mesalazine—CHUK—epithelium—Barrett's esophagus	0.00432	0.141	CbGeAlD
Mesalazine—CHUK—digestive system—Barrett's esophagus	0.00329	0.107	CbGeAlD
Mesalazine—IKBKB—smooth muscle tissue—Barrett's esophagus	0.00283	0.0923	CbGeAlD
Mesalazine—ALOX5—smooth muscle tissue—Barrett's esophagus	0.00234	0.0765	CbGeAlD
Mesalazine—IKBKB—digestive system—Barrett's esophagus	0.00223	0.0728	CbGeAlD
Mesalazine—MPO—epithelium—Barrett's esophagus	0.00206	0.0671	CbGeAlD
Mesalazine—ALOX5—digestive system—Barrett's esophagus	0.00185	0.0604	CbGeAlD
Mesalazine—PPARG—epithelium—Barrett's esophagus	0.00183	0.0596	CbGeAlD
Mesalazine—PPARG—smooth muscle tissue—Barrett's esophagus	0.00176	0.0574	CbGeAlD
Mesalazine—MPO—digestive system—Barrett's esophagus	0.00157	0.0511	CbGeAlD
Mesalazine—PPARG—Nuclear Receptors—NR1I2—Barrett's esophagus	0.00152	0.0172	CbGpPWpGaD
Mesalazine—Olsalazine—PPARG—Barrett's esophagus	0.0014	0.328	CrCbGaD
Mesalazine—PPARG—digestive system—Barrett's esophagus	0.00139	0.0453	CbGeAlD
Mesalazine—CHUK—NLR Proteins—RELA—Barrett's esophagus	0.0012	0.0136	CbGpPWpGaD
Mesalazine—PPARG—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.0012	0.0136	CbGpPWpGaD
Mesalazine—PTGS1—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.00113	0.0127	CbGpPWpGaD
Mesalazine—IKBKB—NLR Proteins—RELA—Barrett's esophagus	0.00109	0.0123	CbGpPWpGaD
Mesalazine—CHUK—Hair Follicle Development: Induction (Part 1 of 3)—BMP4—Barrett's esophagus	0.000998	0.0113	CbGpPWpGaD
Mesalazine—PTGS1—epithelium—Barrett's esophagus	0.000976	0.0318	CbGeAlD
Mesalazine—PTGS1—smooth muscle tissue—Barrett's esophagus	0.000941	0.0307	CbGeAlD
Mesalazine—PTGS2—epithelium—Barrett's esophagus	0.000933	0.0304	CbGeAlD
Mesalazine—ALOX5—Eicosanoid Synthesis—PTGS2—Barrett's esophagus	0.000917	0.0104	CbGpPWpGaD
Mesalazine—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—BMP4—Barrett's esophagus	0.000905	0.0102	CbGpPWpGaD
Mesalazine—PTGS2—smooth muscle tissue—Barrett's esophagus	0.000899	0.0293	CbGeAlD
Mesalazine—CHUK—Osteopontin Signaling—RELA—Barrett's esophagus	0.000896	0.0101	CbGpPWpGaD
Mesalazine—PTGS2—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000895	0.0101	CbGpPWpGaD
Mesalazine—Salicylate-sodium—PTGS2—Barrett's esophagus	0.00086	0.202	CrCbGaD
Mesalazine—CHUK—Apoptosis—MCL1—Barrett's esophagus	0.000827	0.00934	CbGpPWpGaD
Mesalazine—IKBKB—Osteopontin Signaling—RELA—Barrett's esophagus	0.000813	0.00918	CbGpPWpGaD
Mesalazine—IKBKB—NF-kB is activated and signals survival—RELA—Barrett's esophagus	0.000813	0.00918	CbGpPWpGaD
Mesalazine—IKBKB—Atypical NF-kappaB pathway—RELA—Barrett's esophagus	0.000766	0.00865	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis—MCL1—Barrett's esophagus	0.00075	0.00847	CbGpPWpGaD
Mesalazine—PTGS1—digestive system—Barrett's esophagus	0.000743	0.0242	CbGeAlD
Mesalazine—PTGS2—digestive system—Barrett's esophagus	0.00071	0.0232	CbGeAlD
Mesalazine—CHUK—BDNF signaling pathway—CRTC1—Barrett's esophagus	0.000709	0.008	CbGpPWpGaD
Mesalazine—MPO—IL23-mediated signaling events—RELA—Barrett's esophagus	0.000708	0.00799	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis Modulation and Signaling—MCL1—Barrett's esophagus	0.000703	0.00794	CbGpPWpGaD
Mesalazine—IKBKB—p75NTR signals via NF-kB—RELA—Barrett's esophagus	0.000688	0.00777	CbGpPWpGaD
Mesalazine—IKBKB—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—Barrett's esophagus	0.000669	0.00755	CbGpPWpGaD
Mesalazine—PTGS2—Signaling mediated by p38-alpha and p38-beta—SLC9A1—Barrett's esophagus	0.00065	0.00735	CbGpPWpGaD
Mesalazine—IKBKB—BDNF signaling pathway—CRTC1—Barrett's esophagus	0.000643	0.00726	CbGpPWpGaD
Mesalazine—Ear pain—Omeprazole—Barrett's esophagus	0.000626	0.00327	CcSEcCtD
Mesalazine—Lymphadenopathy—Omeprazole—Barrett's esophagus	0.000626	0.00327	CcSEcCtD
Mesalazine—Blood alkaline phosphatase increased—Omeprazole—Barrett's esophagus	0.000614	0.00321	CcSEcCtD
Mesalazine—Blood alkaline phosphatase increased—Esomeprazole—Barrett's esophagus	0.000614	0.00321	CcSEcCtD
Mesalazine—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—Barrett's esophagus	0.000612	0.00692	CbGpPWpGaD
Mesalazine—CHUK—RIP-mediated NFkB activation via ZBP1—RELA—Barrett's esophagus	0.000611	0.0069	CbGpPWpGaD
Mesalazine—Photosensitivity—Omeprazole—Barrett's esophagus	0.000609	0.00318	CcSEcCtD
Mesalazine—Photosensitivity—Esomeprazole—Barrett's esophagus	0.000609	0.00318	CcSEcCtD
Mesalazine—Gastroenteritis—Omeprazole—Barrett's esophagus	0.000603	0.00315	CcSEcCtD
Mesalazine—Gastroenteritis—Esomeprazole—Barrett's esophagus	0.000603	0.00315	CcSEcCtD
Mesalazine—PTGS1—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000599	0.00676	CbGpPWpGaD
Mesalazine—Hepatic failure—Esomeprazole—Barrett's esophagus	0.000595	0.00311	CcSEcCtD
Mesalazine—Hepatic failure—Omeprazole—Barrett's esophagus	0.000595	0.00311	CcSEcCtD
Mesalazine—Olsalazine—PTGS2—Barrett's esophagus	0.00059	0.138	CrCbGaD
Mesalazine—PPARG—Circadian rythm related genes—CRTC1—Barrett's esophagus	0.000578	0.00653	CbGpPWpGaD
Mesalazine—Increased appetite—Omeprazole—Barrett's esophagus	0.000569	0.00297	CcSEcCtD
Mesalazine—Increased appetite—Esomeprazole—Barrett's esophagus	0.000569	0.00297	CcSEcCtD
Mesalazine—PPARG—Adipogenesis—CYP26A1—Barrett's esophagus	0.000568	0.00641	CbGpPWpGaD
Mesalazine—CHUK—FCERI mediated NF-kB activation—RELA—Barrett's esophagus	0.000568	0.00641	CbGpPWpGaD
Mesalazine—CHUK—EBV LMP1 signaling—RELA—Barrett's esophagus	0.000568	0.00641	CbGpPWpGaD
Mesalazine—CHUK—Canonical NF-kappaB pathway—RELA—Barrett's esophagus	0.000568	0.00641	CbGpPWpGaD
Mesalazine—Renal impairment—Omeprazole—Barrett's esophagus	0.000562	0.00293	CcSEcCtD
Mesalazine—Thirst—Omeprazole—Barrett's esophagus	0.000562	0.00293	CcSEcCtD
Mesalazine—Renal impairment—Esomeprazole—Barrett's esophagus	0.000562	0.00293	CcSEcCtD
Mesalazine—Thirst—Esomeprazole—Barrett's esophagus	0.000562	0.00293	CcSEcCtD
Mesalazine—Aminosalicylic Acid—PTGS2—Barrett's esophagus	0.000554	0.13	CrCbGaD
Mesalazine—Diflunisal—PTGS2—Barrett's esophagus	0.000554	0.13	CrCbGaD
Mesalazine—IKBKB—RIP-mediated NFkB activation via ZBP1—RELA—Barrett's esophagus	0.000554	0.00625	CbGpPWpGaD
Mesalazine—Arthritis—Esomeprazole—Barrett's esophagus	0.00055	0.00287	CcSEcCtD
Mesalazine—Arthritis—Omeprazole—Barrett's esophagus	0.00055	0.00287	CcSEcCtD
Mesalazine—CHUK—TRAF6 mediated NF-kB activation—RELA—Barrett's esophagus	0.000549	0.0062	CbGpPWpGaD
Mesalazine—MPO—Vitamin B12 Metabolism—RELA—Barrett's esophagus	0.000547	0.00618	CbGpPWpGaD
Mesalazine—CHUK—EBV LMP1 signaling—CXCL8—Barrett's esophagus	0.000535	0.00604	CbGpPWpGaD
Mesalazine—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.000534	0.00279	CcSEcCtD
Mesalazine—Osteoarthritis—Esomeprazole—Barrett's esophagus	0.000534	0.00279	CcSEcCtD
Mesalazine—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.000534	0.00279	CcSEcCtD
Mesalazine—Osteoarthritis—Omeprazole—Barrett's esophagus	0.000534	0.00279	CcSEcCtD
Mesalazine—Migraine—Omeprazole—Barrett's esophagus	0.000526	0.00275	CcSEcCtD
Mesalazine—Migraine—Esomeprazole—Barrett's esophagus	0.000526	0.00275	CcSEcCtD
Mesalazine—Face oedema—Omeprazole—Barrett's esophagus	0.000516	0.00269	CcSEcCtD
Mesalazine—Face oedema—Esomeprazole—Barrett's esophagus	0.000516	0.00269	CcSEcCtD
Mesalazine—IKBKB—Canonical NF-kappaB pathway—RELA—Barrett's esophagus	0.000515	0.00581	CbGpPWpGaD
Mesalazine—IKBKB—EBV LMP1 signaling—RELA—Barrett's esophagus	0.000515	0.00581	CbGpPWpGaD
Mesalazine—IKBKB—FCERI mediated NF-kB activation—RELA—Barrett's esophagus	0.000515	0.00581	CbGpPWpGaD
Mesalazine—CHUK—ZBP1(DAI) mediated induction of type I IFNs—RELA—Barrett's esophagus	0.000515	0.00581	CbGpPWpGaD
Mesalazine—CHUK—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—RELA—Barrett's esophagus	0.000515	0.00581	CbGpPWpGaD
Mesalazine—ALOX5—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.00051	0.00576	CbGpPWpGaD
Mesalazine—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.000501	0.00261	CcSEcCtD
Mesalazine—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.000501	0.00261	CcSEcCtD
Mesalazine—IKBKB—TRAF6 mediated NF-kB activation—RELA—Barrett's esophagus	0.000498	0.00562	CbGpPWpGaD
Mesalazine—Dry skin—Omeprazole—Barrett's esophagus	0.00049	0.00256	CcSEcCtD
Mesalazine—Dry skin—Esomeprazole—Barrett's esophagus	0.00049	0.00256	CcSEcCtD
Mesalazine—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.000488	0.00255	CcSEcCtD
Mesalazine—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.000488	0.00255	CcSEcCtD
Mesalazine—IKBKB—EBV LMP1 signaling—CXCL8—Barrett's esophagus	0.000485	0.00548	CbGpPWpGaD
Mesalazine—Breast disorder—Omeprazole—Barrett's esophagus	0.000483	0.00252	CcSEcCtD
Mesalazine—Breast disorder—Esomeprazole—Barrett's esophagus	0.000483	0.00252	CcSEcCtD
Mesalazine—Cramp muscle—Omeprazole—Barrett's esophagus	0.000481	0.00251	CcSEcCtD
Mesalazine—Cramp muscle—Esomeprazole—Barrett's esophagus	0.000481	0.00251	CcSEcCtD
Mesalazine—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.000481	0.00251	CcSEcCtD
Mesalazine—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.000481	0.00251	CcSEcCtD
Mesalazine—PTGS1—Overview of nanoparticle effects—PTGS2—Barrett's esophagus	0.00048	0.00542	CbGpPWpGaD
Mesalazine—Gastritis—Omeprazole—Barrett's esophagus	0.000473	0.00247	CcSEcCtD
Mesalazine—Gastritis—Esomeprazole—Barrett's esophagus	0.000473	0.00247	CcSEcCtD
Mesalazine—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.000471	0.00246	CcSEcCtD
Mesalazine—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.000471	0.00246	CcSEcCtD
Mesalazine—IKBKB—TAK1 activates NFkB by phosphorylation and activation of IKKs complex—RELA—Barrett's esophagus	0.000467	0.00527	CbGpPWpGaD
Mesalazine—IKBKB—ZBP1(DAI) mediated induction of type I IFNs—RELA—Barrett's esophagus	0.000467	0.00527	CbGpPWpGaD
Mesalazine—PTGS1—Overview of nanoparticle effects—CXCL8—Barrett's esophagus	0.000465	0.00525	CbGpPWpGaD
Mesalazine—Abdominal distension—Omeprazole—Barrett's esophagus	0.000465	0.00243	CcSEcCtD
Mesalazine—Abdominal distension—Esomeprazole—Barrett's esophagus	0.000465	0.00243	CcSEcCtD
Mesalazine—Influenza—Esomeprazole—Barrett's esophagus	0.000462	0.00241	CcSEcCtD
Mesalazine—Asthma—Omeprazole—Barrett's esophagus	0.000462	0.00241	CcSEcCtD
Mesalazine—Dysphagia—Omeprazole—Barrett's esophagus	0.000462	0.00241	CcSEcCtD
Mesalazine—Asthma—Esomeprazole—Barrett's esophagus	0.000462	0.00241	CcSEcCtD
Mesalazine—Influenza—Omeprazole—Barrett's esophagus	0.000462	0.00241	CcSEcCtD
Mesalazine—Dysphagia—Esomeprazole—Barrett's esophagus	0.000462	0.00241	CcSEcCtD
Mesalazine—Bronchospasm—Esomeprazole—Barrett's esophagus	0.000454	0.00237	CcSEcCtD
Mesalazine—Bronchospasm—Omeprazole—Barrett's esophagus	0.000454	0.00237	CcSEcCtD
Mesalazine—Pancreatitis—Esomeprazole—Barrett's esophagus	0.000453	0.00237	CcSEcCtD
Mesalazine—Pancreatitis—Omeprazole—Barrett's esophagus	0.000453	0.00237	CcSEcCtD
Mesalazine—Angina pectoris—Esomeprazole—Barrett's esophagus	0.00045	0.00235	CcSEcCtD
Mesalazine—Angina pectoris—Omeprazole—Barrett's esophagus	0.00045	0.00235	CcSEcCtD
Mesalazine—CHUK—Osteopontin-mediated events—RELA—Barrett's esophagus	0.000447	0.00505	CbGpPWpGaD
Mesalazine—MPO—Folate Metabolism—RELA—Barrett's esophagus	0.000445	0.00503	CbGpPWpGaD
Mesalazine—Pancytopenia—Omeprazole—Barrett's esophagus	0.000439	0.00229	CcSEcCtD
Mesalazine—Pancytopenia—Esomeprazole—Barrett's esophagus	0.000439	0.00229	CcSEcCtD
Mesalazine—Dysuria—Esomeprazole—Barrett's esophagus	0.000432	0.00226	CcSEcCtD
Mesalazine—Neutropenia—Esomeprazole—Barrett's esophagus	0.000432	0.00226	CcSEcCtD
Mesalazine—Dysuria—Omeprazole—Barrett's esophagus	0.000432	0.00226	CcSEcCtD
Mesalazine—Neutropenia—Omeprazole—Barrett's esophagus	0.000432	0.00226	CcSEcCtD
Mesalazine—PPARG—Adipogenesis—BMP4—Barrett's esophagus	0.00043	0.00486	CbGpPWpGaD
Mesalazine—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.000429	0.00224	CcSEcCtD
Mesalazine—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.000429	0.00224	CcSEcCtD
Mesalazine—Pollakiuria—Omeprazole—Barrett's esophagus	0.000427	0.00223	CcSEcCtD
Mesalazine—Pollakiuria—Esomeprazole—Barrett's esophagus	0.000427	0.00223	CcSEcCtD
Mesalazine—CHUK—HIV-1 Nef: Negative effector of Fas and TNF-alpha—RELA—Barrett's esophagus	0.000425	0.0048	CbGpPWpGaD
Mesalazine—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.000422	0.0022	CcSEcCtD
Mesalazine—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.000422	0.0022	CcSEcCtD
Mesalazine—Weight increased—Omeprazole—Barrett's esophagus	0.00042	0.0022	CcSEcCtD
Mesalazine—Weight increased—Esomeprazole—Barrett's esophagus	0.00042	0.0022	CcSEcCtD
Mesalazine—Weight decreased—Esomeprazole—Barrett's esophagus	0.000418	0.00218	CcSEcCtD
Mesalazine—Weight decreased—Omeprazole—Barrett's esophagus	0.000418	0.00218	CcSEcCtD
Mesalazine—CHUK—IL1-mediated signaling events—RELA—Barrett's esophagus	0.000415	0.00469	CbGpPWpGaD
Mesalazine—Infestation—Esomeprazole—Barrett's esophagus	0.000412	0.00215	CcSEcCtD
Mesalazine—Infestation NOS—Omeprazole—Barrett's esophagus	0.000412	0.00215	CcSEcCtD
Mesalazine—Infestation NOS—Esomeprazole—Barrett's esophagus	0.000412	0.00215	CcSEcCtD
Mesalazine—Infestation—Omeprazole—Barrett's esophagus	0.000412	0.00215	CcSEcCtD
Mesalazine—Depression—Omeprazole—Barrett's esophagus	0.000411	0.00214	CcSEcCtD
Mesalazine—Depression—Esomeprazole—Barrett's esophagus	0.000411	0.00214	CcSEcCtD
Mesalazine—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.000408	0.00213	CcSEcCtD
Mesalazine—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.000408	0.00213	CcSEcCtD
Mesalazine—IKBKB—IL17 signaling pathway—RELA—Barrett's esophagus	0.000405	0.00458	CbGpPWpGaD
Mesalazine—Renal failure—Esomeprazole—Barrett's esophagus	0.000405	0.00211	CcSEcCtD
Mesalazine—Renal failure—Omeprazole—Barrett's esophagus	0.000405	0.00211	CcSEcCtD
Mesalazine—PPARG—Wnt Signaling Pathway Netpath—APC—Barrett's esophagus	0.000403	0.00455	CbGpPWpGaD
Mesalazine—Jaundice—Esomeprazole—Barrett's esophagus	0.000401	0.0021	CcSEcCtD
Mesalazine—Stomatitis—Omeprazole—Barrett's esophagus	0.000401	0.0021	CcSEcCtD
Mesalazine—Stomatitis—Esomeprazole—Barrett's esophagus	0.000401	0.0021	CcSEcCtD
Mesalazine—Jaundice—Omeprazole—Barrett's esophagus	0.000401	0.0021	CcSEcCtD
Mesalazine—Urinary tract infection—Omeprazole—Barrett's esophagus	0.0004	0.00209	CcSEcCtD
Mesalazine—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.0004	0.00209	CcSEcCtD
Mesalazine—Conjunctivitis—Omeprazole—Barrett's esophagus	0.0004	0.00209	CcSEcCtD
Mesalazine—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.0004	0.00209	CcSEcCtD
Mesalazine—PTGS1—Eicosanoid Synthesis—PTGS2—Barrett's esophagus	0.000398	0.00449	CbGpPWpGaD
Mesalazine—Haematuria—Omeprazole—Barrett's esophagus	0.000393	0.00205	CcSEcCtD
Mesalazine—Haematuria—Esomeprazole—Barrett's esophagus	0.000393	0.00205	CcSEcCtD
Mesalazine—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.000389	0.00203	CcSEcCtD
Mesalazine—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.000389	0.00203	CcSEcCtD
Mesalazine—Epistaxis—Omeprazole—Barrett's esophagus	0.000388	0.00203	CcSEcCtD
Mesalazine—Epistaxis—Esomeprazole—Barrett's esophagus	0.000388	0.00203	CcSEcCtD
Mesalazine—Sinusitis—Esomeprazole—Barrett's esophagus	0.000386	0.00202	CcSEcCtD
Mesalazine—Sinusitis—Omeprazole—Barrett's esophagus	0.000386	0.00202	CcSEcCtD
Mesalazine—Agranulocytosis—Esomeprazole—Barrett's esophagus	0.000384	0.00201	CcSEcCtD
Mesalazine—Agranulocytosis—Omeprazole—Barrett's esophagus	0.000384	0.00201	CcSEcCtD
Mesalazine—MPO—C-MYB transcription factor network—CDKN2A—Barrett's esophagus	0.000382	0.00431	CbGpPWpGaD
Mesalazine—IKBKB—IL1-mediated signaling events—RELA—Barrett's esophagus	0.000377	0.00425	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000372	0.0042	CbGpPWpGaD
Mesalazine—Rhinitis—Omeprazole—Barrett's esophagus	0.000371	0.00194	CcSEcCtD
Mesalazine—Rhinitis—Esomeprazole—Barrett's esophagus	0.000371	0.00194	CcSEcCtD
Mesalazine—Hepatitis—Esomeprazole—Barrett's esophagus	0.00037	0.00193	CcSEcCtD
Mesalazine—Hepatitis—Omeprazole—Barrett's esophagus	0.00037	0.00193	CcSEcCtD
Mesalazine—PTGS2—Overview of nanoparticle effects—CXCL8—Barrett's esophagus	0.000369	0.00417	CbGpPWpGaD
Mesalazine—Pharyngitis—Omeprazole—Barrett's esophagus	0.000367	0.00192	CcSEcCtD
Mesalazine—Pharyngitis—Esomeprazole—Barrett's esophagus	0.000367	0.00192	CcSEcCtD
Mesalazine—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.000365	0.00191	CcSEcCtD
Mesalazine—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.000365	0.00191	CcSEcCtD
Mesalazine—Oedema peripheral—Omeprazole—Barrett's esophagus	0.000364	0.0019	CcSEcCtD
Mesalazine—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.000364	0.0019	CcSEcCtD
Mesalazine—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.000363	0.0019	CcSEcCtD
Mesalazine—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.000363	0.0019	CcSEcCtD
Mesalazine—Urethral disorder—Omeprazole—Barrett's esophagus	0.000362	0.00189	CcSEcCtD
Mesalazine—Urethral disorder—Esomeprazole—Barrett's esophagus	0.000362	0.00189	CcSEcCtD
Mesalazine—CHUK—NOD pathway—RELA—Barrett's esophagus	0.000357	0.00404	CbGpPWpGaD
Mesalazine—CHUK—Downstream TCR signaling—RELA—Barrett's esophagus	0.000357	0.00404	CbGpPWpGaD
Mesalazine—MPO—C-MYB transcription factor network—PTGS2—Barrett's esophagus	0.000357	0.00403	CbGpPWpGaD
Mesalazine—MPO—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.000354	0.004	CbGpPWpGaD
Mesalazine—CHUK—TWEAK Signaling Pathway—RELA—Barrett's esophagus	0.000351	0.00396	CbGpPWpGaD
Mesalazine—Erythema multiforme—Omeprazole—Barrett's esophagus	0.00035	0.00183	CcSEcCtD
Mesalazine—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.00035	0.00183	CcSEcCtD
Mesalazine—Eye disorder—Esomeprazole—Barrett's esophagus	0.000345	0.0018	CcSEcCtD
Mesalazine—Eye disorder—Omeprazole—Barrett's esophagus	0.000345	0.0018	CcSEcCtD
Mesalazine—Tinnitus—Esomeprazole—Barrett's esophagus	0.000345	0.0018	CcSEcCtD
Mesalazine—Tinnitus—Omeprazole—Barrett's esophagus	0.000345	0.0018	CcSEcCtD
Mesalazine—MPO—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	0.000344	0.00388	CbGpPWpGaD
Mesalazine—CHUK—Interleukin-11 Signaling Pathway—RELA—Barrett's esophagus	0.000338	0.00382	CbGpPWpGaD
Mesalazine—ALOX5—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.000334	0.00377	CbGpPWpGaD
Mesalazine—Immune system disorder—Omeprazole—Barrett's esophagus	0.000334	0.00174	CcSEcCtD
Mesalazine—Immune system disorder—Esomeprazole—Barrett's esophagus	0.000334	0.00174	CcSEcCtD
Mesalazine—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.000333	0.00174	CcSEcCtD
Mesalazine—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.000333	0.00174	CcSEcCtD
Mesalazine—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—Barrett's esophagus	0.000333	0.00376	CbGpPWpGaD
Mesalazine—Chills—Esomeprazole—Barrett's esophagus	0.000332	0.00173	CcSEcCtD
Mesalazine—Chills—Omeprazole—Barrett's esophagus	0.000332	0.00173	CcSEcCtD
Mesalazine—Alopecia—Esomeprazole—Barrett's esophagus	0.000327	0.00171	CcSEcCtD
Mesalazine—Alopecia—Omeprazole—Barrett's esophagus	0.000327	0.00171	CcSEcCtD
Mesalazine—CHUK—TNF receptor signaling pathway —RELA—Barrett's esophagus	0.000326	0.00368	CbGpPWpGaD
Mesalazine—ALOX5—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	0.000324	0.00367	CbGpPWpGaD
Mesalazine—IKBKB—NOD pathway—RELA—Barrett's esophagus	0.000324	0.00366	CbGpPWpGaD
Mesalazine—IKBKB—Downstream TCR signaling—RELA—Barrett's esophagus	0.000324	0.00366	CbGpPWpGaD
Mesalazine—Mental disorder—Esomeprazole—Barrett's esophagus	0.000324	0.00169	CcSEcCtD
Mesalazine—Mental disorder—Omeprazole—Barrett's esophagus	0.000324	0.00169	CcSEcCtD
Mesalazine—CHUK—Structural Pathway of Interleukin 1 (IL-1)—RELA—Barrett's esophagus	0.00032	0.00362	CbGpPWpGaD
Mesalazine—IKBKB—TWEAK Signaling Pathway—RELA—Barrett's esophagus	0.000318	0.00359	CbGpPWpGaD
Mesalazine—PTGS1—Biological oxidations—CYP26A1—Barrett's esophagus	0.000318	0.00359	CbGpPWpGaD
Mesalazine—Flatulence—Omeprazole—Barrett's esophagus	0.000317	0.00166	CcSEcCtD
Mesalazine—Flatulence—Esomeprazole—Barrett's esophagus	0.000317	0.00166	CcSEcCtD
Mesalazine—Tension—Esomeprazole—Barrett's esophagus	0.000316	0.00165	CcSEcCtD
Mesalazine—Tension—Omeprazole—Barrett's esophagus	0.000316	0.00165	CcSEcCtD
Mesalazine—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—Barrett's esophagus	0.000316	0.00357	CbGpPWpGaD
Mesalazine—Dysgeusia—Esomeprazole—Barrett's esophagus	0.000315	0.00165	CcSEcCtD
Mesalazine—Dysgeusia—Omeprazole—Barrett's esophagus	0.000315	0.00165	CcSEcCtD
Mesalazine—Nervousness—Esomeprazole—Barrett's esophagus	0.000313	0.00163	CcSEcCtD
Mesalazine—Nervousness—Omeprazole—Barrett's esophagus	0.000313	0.00163	CcSEcCtD
Mesalazine—Back pain—Omeprazole—Barrett's esophagus	0.000311	0.00163	CcSEcCtD
Mesalazine—Back pain—Esomeprazole—Barrett's esophagus	0.000311	0.00163	CcSEcCtD
Mesalazine—Muscle spasms—Omeprazole—Barrett's esophagus	0.000309	0.00162	CcSEcCtD
Mesalazine—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000309	0.00162	CcSEcCtD
Mesalazine—Salicylic acid—PTGS2—Barrett's esophagus	0.000308	0.0723	CrCbGaD
Mesalazine—IKBKB—Interleukin-11 Signaling Pathway—RELA—Barrett's esophagus	0.000306	0.00346	CbGpPWpGaD
Mesalazine—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Barrett's esophagus	0.000306	0.00346	CbGpPWpGaD
Mesalazine—CHUK—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—RELA—Barrett's esophagus	0.000305	0.00345	CbGpPWpGaD
Mesalazine—Vision blurred—Esomeprazole—Barrett's esophagus	0.000303	0.00158	CcSEcCtD
Mesalazine—Vision blurred—Omeprazole—Barrett's esophagus	0.000303	0.00158	CcSEcCtD
Mesalazine—Tremor—Esomeprazole—Barrett's esophagus	0.000302	0.00157	CcSEcCtD
Mesalazine—Tremor—Omeprazole—Barrett's esophagus	0.000302	0.00157	CcSEcCtD
Mesalazine—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000299	0.00156	CcSEcCtD
Mesalazine—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000299	0.00156	CcSEcCtD
Mesalazine—CHUK—Validated transcriptional targets of TAp63 isoforms—CDKN2A—Barrett's esophagus	0.000298	0.00337	CbGpPWpGaD
Mesalazine—Anaemia—Omeprazole—Barrett's esophagus	0.000297	0.00155	CcSEcCtD
Mesalazine—Anaemia—Esomeprazole—Barrett's esophagus	0.000297	0.00155	CcSEcCtD
Mesalazine—IKBKB—TNF receptor signaling pathway —RELA—Barrett's esophagus	0.000296	0.00334	CbGpPWpGaD
Mesalazine—Angioedema—Esomeprazole—Barrett's esophagus	0.000294	0.00154	CcSEcCtD
Mesalazine—Angioedema—Omeprazole—Barrett's esophagus	0.000294	0.00154	CcSEcCtD
Mesalazine—IKBKB—Structural Pathway of Interleukin 1 (IL-1)—RELA—Barrett's esophagus	0.000291	0.00328	CbGpPWpGaD
Mesalazine—Malaise—Omeprazole—Barrett's esophagus	0.00029	0.00152	CcSEcCtD
Mesalazine—Malaise—Esomeprazole—Barrett's esophagus	0.00029	0.00152	CcSEcCtD
Mesalazine—Vertigo—Esomeprazole—Barrett's esophagus	0.000289	0.00151	CcSEcCtD
Mesalazine—Vertigo—Omeprazole—Barrett's esophagus	0.000289	0.00151	CcSEcCtD
Mesalazine—Leukopenia—Omeprazole—Barrett's esophagus	0.000288	0.0015	CcSEcCtD
Mesalazine—Leukopenia—Esomeprazole—Barrett's esophagus	0.000288	0.0015	CcSEcCtD
Mesalazine—CHUK—IL-4 Signaling Pathway—RELA—Barrett's esophagus	0.000287	0.00324	CbGpPWpGaD
Mesalazine—Palpitations—Omeprazole—Barrett's esophagus	0.000284	0.00149	CcSEcCtD
Mesalazine—Palpitations—Esomeprazole—Barrett's esophagus	0.000284	0.00149	CcSEcCtD
Mesalazine—CHUK—Signaling by Interleukins—HGF—Barrett's esophagus	0.000284	0.00321	CbGpPWpGaD
Mesalazine—CHUK—IL-1 signaling pathway—RELA—Barrett's esophagus	0.000283	0.00319	CbGpPWpGaD
Mesalazine—CHUK—RANKL/RANK Signaling Pathway—RELA—Barrett's esophagus	0.000283	0.00319	CbGpPWpGaD
Mesalazine—Cough—Omeprazole—Barrett's esophagus	0.000281	0.00147	CcSEcCtD
Mesalazine—Cough—Esomeprazole—Barrett's esophagus	0.000281	0.00147	CcSEcCtD
Mesalazine—Hypertension—Esomeprazole—Barrett's esophagus	0.000278	0.00145	CcSEcCtD
Mesalazine—Hypertension—Omeprazole—Barrett's esophagus	0.000278	0.00145	CcSEcCtD
Mesalazine—IKBKB—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—RELA—Barrett's esophagus	0.000277	0.00312	CbGpPWpGaD
Mesalazine—Chest pain—Esomeprazole—Barrett's esophagus	0.000274	0.00143	CcSEcCtD
Mesalazine—Myalgia—Omeprazole—Barrett's esophagus	0.000274	0.00143	CcSEcCtD
Mesalazine—Chest pain—Omeprazole—Barrett's esophagus	0.000274	0.00143	CcSEcCtD
Mesalazine—Arthralgia—Esomeprazole—Barrett's esophagus	0.000274	0.00143	CcSEcCtD
Mesalazine—Myalgia—Esomeprazole—Barrett's esophagus	0.000274	0.00143	CcSEcCtD
Mesalazine—Arthralgia—Omeprazole—Barrett's esophagus	0.000274	0.00143	CcSEcCtD
Mesalazine—Anxiety—Esomeprazole—Barrett's esophagus	0.000273	0.00143	CcSEcCtD
Mesalazine—Anxiety—Omeprazole—Barrett's esophagus	0.000273	0.00143	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000272	0.00142	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000272	0.00142	CcSEcCtD
Mesalazine—Discomfort—Omeprazole—Barrett's esophagus	0.000271	0.00141	CcSEcCtD
Mesalazine—Discomfort—Esomeprazole—Barrett's esophagus	0.000271	0.00141	CcSEcCtD
Mesalazine—PPARG—Regulation of retinoblastoma protein—CDKN2A—Barrett's esophagus	0.00027	0.00305	CbGpPWpGaD
Mesalazine—IKBKB—Validated transcriptional targets of TAp63 isoforms—CDKN2A—Barrett's esophagus	0.00027	0.00305	CbGpPWpGaD
Mesalazine—Dry mouth—Omeprazole—Barrett's esophagus	0.000268	0.0014	CcSEcCtD
Mesalazine—Dry mouth—Esomeprazole—Barrett's esophagus	0.000268	0.0014	CcSEcCtD
Mesalazine—CHUK—TCR signaling—RELA—Barrett's esophagus	0.000267	0.00302	CbGpPWpGaD
Mesalazine—Confusional state—Esomeprazole—Barrett's esophagus	0.000265	0.00138	CcSEcCtD
Mesalazine—Confusional state—Omeprazole—Barrett's esophagus	0.000265	0.00138	CcSEcCtD
Mesalazine—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.000263	0.00137	CcSEcCtD
Mesalazine—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.000263	0.00137	CcSEcCtD
Mesalazine—Infection—Omeprazole—Barrett's esophagus	0.000261	0.00136	CcSEcCtD
Mesalazine—Infection—Esomeprazole—Barrett's esophagus	0.000261	0.00136	CcSEcCtD
Mesalazine—CHUK—Fc-epsilon receptor I signaling in mast cells—RELA—Barrett's esophagus	0.00026	0.00294	CbGpPWpGaD
Mesalazine—IKBKB—IL-4 Signaling Pathway—RELA—Barrett's esophagus	0.00026	0.00294	CbGpPWpGaD
Mesalazine—Shock—Esomeprazole—Barrett's esophagus	0.000258	0.00135	CcSEcCtD
Mesalazine—Shock—Omeprazole—Barrett's esophagus	0.000258	0.00135	CcSEcCtD
Mesalazine—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000258	0.00135	CcSEcCtD
Mesalazine—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000258	0.00135	CcSEcCtD
Mesalazine—MPO—Folate Metabolism—TP53—Barrett's esophagus	0.000258	0.00291	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by Interleukins—HGF—Barrett's esophagus	0.000257	0.00291	CbGpPWpGaD
Mesalazine—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000257	0.00134	CcSEcCtD
Mesalazine—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000257	0.00134	CcSEcCtD
Mesalazine—Tachycardia—Esomeprazole—Barrett's esophagus	0.000256	0.00134	CcSEcCtD
Mesalazine—Tachycardia—Omeprazole—Barrett's esophagus	0.000256	0.00134	CcSEcCtD
Mesalazine—IKBKB—IL-1 signaling pathway—RELA—Barrett's esophagus	0.000256	0.00289	CbGpPWpGaD
Mesalazine—IKBKB—RANKL/RANK Signaling Pathway—RELA—Barrett's esophagus	0.000256	0.00289	CbGpPWpGaD
Mesalazine—Skin disorder—Esomeprazole—Barrett's esophagus	0.000255	0.00133	CcSEcCtD
Mesalazine—Skin disorder—Omeprazole—Barrett's esophagus	0.000255	0.00133	CcSEcCtD
Mesalazine—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000254	0.00133	CcSEcCtD
Mesalazine—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000254	0.00133	CcSEcCtD
Mesalazine—Anorexia—Esomeprazole—Barrett's esophagus	0.00025	0.00131	CcSEcCtD
Mesalazine—Anorexia—Omeprazole—Barrett's esophagus	0.00025	0.00131	CcSEcCtD
Mesalazine—PPARG—Signaling events mediated by HDAC Class I—RELA—Barrett's esophagus	0.000248	0.0028	CbGpPWpGaD
Mesalazine—CHUK—Activation of NF-kappaB in B cells—RELA—Barrett's esophagus	0.000247	0.00279	CbGpPWpGaD
Mesalazine—CHUK—Cytosolic sensors of pathogen-associated DNA—RELA—Barrett's esophagus	0.000244	0.00276	CbGpPWpGaD
Mesalazine—CHUK—AGE/RAGE pathway—RELA—Barrett's esophagus	0.000244	0.00276	CbGpPWpGaD
Mesalazine—IKBKB—TCR signaling—RELA—Barrett's esophagus	0.000242	0.00274	CbGpPWpGaD
Mesalazine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—RELA—Barrett's esophagus	0.000241	0.00273	CbGpPWpGaD
Mesalazine—CHUK—BCR signaling pathway—RELA—Barrett's esophagus	0.000241	0.00273	CbGpPWpGaD
Mesalazine—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000239	0.00125	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000239	0.00125	CcSEcCtD
Mesalazine—Insomnia—Omeprazole—Barrett's esophagus	0.000238	0.00124	CcSEcCtD
Mesalazine—Insomnia—Esomeprazole—Barrett's esophagus	0.000238	0.00124	CcSEcCtD
Mesalazine—IKBKB—Fc-epsilon receptor I signaling in mast cells—RELA—Barrett's esophagus	0.000236	0.00266	CbGpPWpGaD
Mesalazine—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000236	0.00123	CcSEcCtD
Mesalazine—Paraesthesia—Omeprazole—Barrett's esophagus	0.000236	0.00123	CcSEcCtD
Mesalazine—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000234	0.00122	CcSEcCtD
Mesalazine—Dyspnoea—Omeprazole—Barrett's esophagus	0.000234	0.00122	CcSEcCtD
Mesalazine—Somnolence—Esomeprazole—Barrett's esophagus	0.000233	0.00122	CcSEcCtD
Mesalazine—Somnolence—Omeprazole—Barrett's esophagus	0.000233	0.00122	CcSEcCtD
Mesalazine—Dyspepsia—Omeprazole—Barrett's esophagus	0.000231	0.00121	CcSEcCtD
Mesalazine—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000231	0.00121	CcSEcCtD
Mesalazine—PPARG—Transcriptional regulation of white adipocyte differentiation—RELA—Barrett's esophagus	0.00023	0.0026	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.00023	0.0026	CbGpPWpGaD
Mesalazine—Decreased appetite—Omeprazole—Barrett's esophagus	0.000228	0.00119	CcSEcCtD
Mesalazine—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000228	0.00119	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000227	0.00118	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000227	0.00118	CcSEcCtD
Mesalazine—Fatigue—Omeprazole—Barrett's esophagus	0.000226	0.00118	CcSEcCtD
Mesalazine—Fatigue—Esomeprazole—Barrett's esophagus	0.000226	0.00118	CcSEcCtD
Mesalazine—Constipation—Omeprazole—Barrett's esophagus	0.000225	0.00117	CcSEcCtD
Mesalazine—Pain—Esomeprazole—Barrett's esophagus	0.000225	0.00117	CcSEcCtD
Mesalazine—Pain—Omeprazole—Barrett's esophagus	0.000225	0.00117	CcSEcCtD
Mesalazine—Constipation—Esomeprazole—Barrett's esophagus	0.000225	0.00117	CcSEcCtD
Mesalazine—IKBKB—Activation of NF-kappaB in B cells—RELA—Barrett's esophagus	0.000224	0.00253	CbGpPWpGaD
Mesalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—Barrett's esophagus	0.000223	0.00252	CbGpPWpGaD
Mesalazine—IKBKB—Cytosolic sensors of pathogen-associated DNA—RELA—Barrett's esophagus	0.000221	0.0025	CbGpPWpGaD
Mesalazine—IKBKB—AGE/RAGE pathway—RELA—Barrett's esophagus	0.000221	0.0025	CbGpPWpGaD
Mesalazine—PTGS1—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000221	0.0025	CbGpPWpGaD
Mesalazine—CHUK—Leptin signaling pathway—RELA—Barrett's esophagus	0.000221	0.00249	CbGpPWpGaD
Mesalazine—CHUK—TRAF6 Mediated Induction of proinflammatory cytokines—RELA—Barrett's esophagus	0.000221	0.00249	CbGpPWpGaD
Mesalazine—IKBKB—BCR signaling pathway—RELA—Barrett's esophagus	0.000219	0.00247	CbGpPWpGaD
Mesalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—RELA—Barrett's esophagus	0.000219	0.00247	CbGpPWpGaD
Mesalazine—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000216	0.00113	CcSEcCtD
Mesalazine—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000216	0.00113	CcSEcCtD
Mesalazine—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000215	0.00112	CcSEcCtD
Mesalazine—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000215	0.00112	CcSEcCtD
Mesalazine—CHUK—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—RELA—Barrett's esophagus	0.000209	0.00237	CbGpPWpGaD
Mesalazine—CHUK—Apoptosis—CDKN2A—Barrett's esophagus	0.000209	0.00236	CbGpPWpGaD
Mesalazine—Urticaria—Esomeprazole—Barrett's esophagus	0.000209	0.00109	CcSEcCtD
Mesalazine—Urticaria—Omeprazole—Barrett's esophagus	0.000209	0.00109	CcSEcCtD
Mesalazine—Body temperature increased—Omeprazole—Barrett's esophagus	0.000208	0.00108	CcSEcCtD
Mesalazine—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000208	0.00108	CcSEcCtD
Mesalazine—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000208	0.00108	CcSEcCtD
Mesalazine—Abdominal pain—Omeprazole—Barrett's esophagus	0.000208	0.00108	CcSEcCtD
Mesalazine—PPARG—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000207	0.00234	CbGpPWpGaD
Mesalazine—CHUK—Apoptosis—RELA—Barrett's esophagus	0.000201	0.00227	CbGpPWpGaD
Mesalazine—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—RELA—Barrett's esophagus	0.0002	0.00226	CbGpPWpGaD
Mesalazine—IKBKB—Leptin signaling pathway—RELA—Barrett's esophagus	0.0002	0.00226	CbGpPWpGaD
Mesalazine—CHUK—MyD88 cascade initiated on plasma membrane—RELA—Barrett's esophagus	0.0002	0.00225	CbGpPWpGaD
Mesalazine—CHUK—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RELA—Barrett's esophagus	0.000198	0.00223	CbGpPWpGaD
Mesalazine—CHUK—MyD88 dependent cascade initiated on endosome—RELA—Barrett's esophagus	0.000194	0.00219	CbGpPWpGaD
Mesalazine—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000194	0.00101	CcSEcCtD
Mesalazine—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000194	0.00101	CcSEcCtD
Mesalazine—PTGS2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000193	0.00218	CbGpPWpGaD
Mesalazine—CHUK—TCR Signaling Pathway—RELA—Barrett's esophagus	0.000191	0.00215	CbGpPWpGaD
Mesalazine—IKBKB—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—RELA—Barrett's esophagus	0.00019	0.00214	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis—CDKN2A—Barrett's esophagus	0.00019	0.00214	CbGpPWpGaD
Mesalazine—Asthenia—Esomeprazole—Barrett's esophagus	0.000188	0.000984	CcSEcCtD
Mesalazine—Asthenia—Omeprazole—Barrett's esophagus	0.000188	0.000984	CcSEcCtD
Mesalazine—CHUK—Toll Like Receptor 9 (TLR9) Cascade—RELA—Barrett's esophagus	0.000187	0.00212	CbGpPWpGaD
Mesalazine—IKBKB—p75 NTR receptor-mediated signalling—RELA—Barrett's esophagus	0.000186	0.0021	CbGpPWpGaD
Mesalazine—Pruritus—Omeprazole—Barrett's esophagus	0.000186	0.000971	CcSEcCtD
Mesalazine—Pruritus—Esomeprazole—Barrett's esophagus	0.000186	0.000971	CcSEcCtD
Mesalazine—CHUK—MyD88:Mal cascade initiated on plasma membrane—RELA—Barrett's esophagus	0.000184	0.00208	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis—RELA—Barrett's esophagus	0.000183	0.00206	CbGpPWpGaD
Mesalazine—IKBKB—MyD88 cascade initiated on plasma membrane—RELA—Barrett's esophagus	0.000181	0.00204	CbGpPWpGaD
Mesalazine—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00018	0.000939	CcSEcCtD
Mesalazine—Diarrhoea—Omeprazole—Barrett's esophagus	0.00018	0.000939	CcSEcCtD
Mesalazine—CHUK—B Cell Receptor Signaling Pathway—RELA—Barrett's esophagus	0.00018	0.00203	CbGpPWpGaD
Mesalazine—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RELA—Barrett's esophagus	0.000179	0.00202	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis Modulation and Signaling—CDKN2A—Barrett's esophagus	0.000178	0.00201	CbGpPWpGaD
Mesalazine—CHUK—MyD88-independent cascade—RELA—Barrett's esophagus	0.000177	0.00199	CbGpPWpGaD
Mesalazine—IKBKB—MyD88 dependent cascade initiated on endosome—RELA—Barrett's esophagus	0.000176	0.00199	CbGpPWpGaD
Mesalazine—Dizziness—Omeprazole—Barrett's esophagus	0.000174	0.000907	CcSEcCtD
Mesalazine—Dizziness—Esomeprazole—Barrett's esophagus	0.000174	0.000907	CcSEcCtD
Mesalazine—IKBKB—TCR Signaling Pathway—RELA—Barrett's esophagus	0.000173	0.00195	CbGpPWpGaD
Mesalazine—CHUK—Toll-like Receptor Signaling Pathway—RELA—Barrett's esophagus	0.000172	0.00195	CbGpPWpGaD
Mesalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Barrett's esophagus	0.00017	0.00192	CbGpPWpGaD
Mesalazine—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—RELA—Barrett's esophagus	0.00017	0.00192	CbGpPWpGaD
Mesalazine—CHUK—BDNF signaling pathway—APC—Barrett's esophagus	0.000167	0.00189	CbGpPWpGaD
Mesalazine—Vomiting—Esomeprazole—Barrett's esophagus	0.000167	0.000872	CcSEcCtD
Mesalazine—Vomiting—Omeprazole—Barrett's esophagus	0.000167	0.000872	CcSEcCtD
Mesalazine—IKBKB—MyD88:Mal cascade initiated on plasma membrane—RELA—Barrett's esophagus	0.000167	0.00189	CbGpPWpGaD
Mesalazine—Rash—Omeprazole—Barrett's esophagus	0.000166	0.000865	CcSEcCtD
Mesalazine—Rash—Esomeprazole—Barrett's esophagus	0.000166	0.000865	CcSEcCtD
Mesalazine—ALOX5—Metabolism—PTGES—Barrett's esophagus	0.000165	0.00187	CbGpPWpGaD
Mesalazine—Dermatitis—Omeprazole—Barrett's esophagus	0.000165	0.000864	CcSEcCtD
Mesalazine—Dermatitis—Esomeprazole—Barrett's esophagus	0.000165	0.000864	CcSEcCtD
Mesalazine—CHUK—Signaling by Interleukins—RELA—Barrett's esophagus	0.000165	0.00186	CbGpPWpGaD
Mesalazine—Headache—Esomeprazole—Barrett's esophagus	0.000165	0.000859	CcSEcCtD
Mesalazine—Headache—Omeprazole—Barrett's esophagus	0.000165	0.000859	CcSEcCtD
Mesalazine—IKBKB—B Cell Receptor Signaling Pathway—RELA—Barrett's esophagus	0.000163	0.00184	CbGpPWpGaD
Mesalazine—CHUK—Toll-like Receptor Signaling Pathway—CXCL8—Barrett's esophagus	0.000162	0.00184	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000161	0.00182	CbGpPWpGaD
Mesalazine—IKBKB—MyD88-independent cascade—RELA—Barrett's esophagus	0.00016	0.00181	CbGpPWpGaD
Mesalazine—CHUK—Activated TLR4 signalling—RELA—Barrett's esophagus	0.000159	0.00179	CbGpPWpGaD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—RELA—Barrett's esophagus	0.000156	0.00177	CbGpPWpGaD
Mesalazine—Nausea—Esomeprazole—Barrett's esophagus	0.000156	0.000815	CcSEcCtD
Mesalazine—Nausea—Omeprazole—Barrett's esophagus	0.000156	0.000815	CcSEcCtD
Mesalazine—IKBKB—BDNF signaling pathway—APC—Barrett's esophagus	0.000152	0.00172	CbGpPWpGaD
Mesalazine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—RELA—Barrett's esophagus	0.000149	0.00169	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by Interleukins—RELA—Barrett's esophagus	0.000149	0.00169	CbGpPWpGaD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—CXCL8—Barrett's esophagus	0.000147	0.00166	CbGpPWpGaD
Mesalazine—PTGS1—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.000145	0.00164	CbGpPWpGaD
Mesalazine—IKBKB—Activated TLR4 signalling—RELA—Barrett's esophagus	0.000144	0.00163	CbGpPWpGaD
Mesalazine—PTGS1—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	0.000141	0.00159	CbGpPWpGaD
Mesalazine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—TP53—Barrett's esophagus	0.00014	0.00158	CbGpPWpGaD
Mesalazine—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—Barrett's esophagus	0.000139	0.00157	CbGpPWpGaD
Mesalazine—CHUK—p75(NTR)-mediated signaling—TP53—Barrett's esophagus	0.000136	0.00154	CbGpPWpGaD
Mesalazine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—RELA—Barrett's esophagus	0.000135	0.00153	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—RELA—Barrett's esophagus	0.000135	0.00152	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000134	0.00151	CbGpPWpGaD
Mesalazine—CHUK—Toll-Like Receptors Cascades—RELA—Barrett's esophagus	0.000133	0.0015	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—HGF—Barrett's esophagus	0.000132	0.0015	CbGpPWpGaD
Mesalazine—CHUK—BDNF signaling pathway—RELA—Barrett's esophagus	0.000131	0.00148	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000128	0.00144	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—CXCL8—Barrett's esophagus	0.000127	0.00143	CbGpPWpGaD
Mesalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—Barrett's esophagus	0.000127	0.00143	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—CYP26A1—Barrett's esophagus	0.000125	0.00142	CbGpPWpGaD
Mesalazine—PTGS2—C-MYB transcription factor network—CDKN2A—Barrett's esophagus	0.000124	0.0014	CbGpPWpGaD
Mesalazine—IKBKB—p75(NTR)-mediated signaling—TP53—Barrett's esophagus	0.000124	0.0014	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—RELA—Barrett's esophagus	0.000122	0.00138	CbGpPWpGaD
Mesalazine—IKBKB—Toll-Like Receptors Cascades—RELA—Barrett's esophagus	0.000121	0.00136	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—HGF—Barrett's esophagus	0.00012	0.00136	CbGpPWpGaD
Mesalazine—IKBKB—BDNF signaling pathway—RELA—Barrett's esophagus	0.000119	0.00134	CbGpPWpGaD
Mesalazine—CHUK—Apoptosis—TP53—Barrett's esophagus	0.000116	0.00132	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.000116	0.00131	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—CXCL8—Barrett's esophagus	0.000115	0.0013	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.000115	0.0013	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.000111	0.00125	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis—TP53—Barrett's esophagus	0.000106	0.00119	CbGpPWpGaD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.000105	0.00119	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—RELA—Barrett's esophagus	0.000103	0.00116	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PTGES—Barrett's esophagus	0.000102	0.00116	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000101	0.00115	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.000101	0.00114	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—NR1I2—Barrett's esophagus	9.98e-05	0.00113	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis Modulation and Signaling—TP53—Barrett's esophagus	9.91e-05	0.00112	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—RELA—Barrett's esophagus	9.31e-05	0.00105	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	9.27e-05	0.00105	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—SLC9A1—Barrett's esophagus	9.04e-05	0.00102	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—CXCL8—Barrett's esophagus	8.57e-05	0.000968	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	7.91e-05	0.000894	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—CYP26A1—Barrett's esophagus	7.76e-05	0.000877	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	7.69e-05	0.000868	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—RELA—Barrett's esophagus	7.56e-05	0.000854	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	7.29e-05	0.000823	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	7.29e-05	0.000823	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PTGES—Barrett's esophagus	7.18e-05	0.00081	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	6.97e-05	0.000787	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—RELA—Barrett's esophagus	6.85e-05	0.000774	CbGpPWpGaD
Mesalazine—CHUK—Disease—SLC9A1—Barrett's esophagus	6.27e-05	0.000709	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—TP53—Barrett's esophagus	6.17e-05	0.000697	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TP53—Barrett's esophagus	6.07e-05	0.000685	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	6.04e-05	0.000682	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—GAST—Barrett's esophagus	5.73e-05	0.000647	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PTGES—Barrett's esophagus	5.7e-05	0.000643	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—SLC9A1—Barrett's esophagus	5.6e-05	0.000632	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CYP26A1—Barrett's esophagus	5.44e-05	0.000614	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TP53—Barrett's esophagus	5.26e-05	0.000594	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—RELA—Barrett's esophagus	5.2e-05	0.000587	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—GAST—Barrett's esophagus	5.19e-05	0.000587	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	4.51e-05	0.00051	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HGF—Barrett's esophagus	4.33e-05	0.000489	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CYP26A1—Barrett's esophagus	4.32e-05	0.000488	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—RELA—Barrett's esophagus	4.31e-05	0.000487	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—RELA—Barrett's esophagus	4.14e-05	0.000468	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—PPARG—Barrett's esophagus	4.13e-05	0.000466	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	4.02e-05	0.000454	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SST—Barrett's esophagus	3.93e-05	0.000444	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HGF—Barrett's esophagus	3.92e-05	0.000443	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—SLC9A1—Barrett's esophagus	3.92e-05	0.000443	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—RELA—Barrett's esophagus	3.91e-05	0.000442	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—RELA—Barrett's esophagus	3.75e-05	0.000424	CbGpPWpGaD
Mesalazine—PTGS2—Disease—SLC9A1—Barrett's esophagus	3.72e-05	0.00042	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	3.58e-05	0.000404	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SST—Barrett's esophagus	3.56e-05	0.000402	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—PTGS2—Barrett's esophagus	3.25e-05	0.000367	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	3.19e-05	0.00036	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	3.16e-05	0.000357	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—SLC9A1—Barrett's esophagus	3.11e-05	0.000351	CbGpPWpGaD
Mesalazine—CHUK—Disease—APC—Barrett's esophagus	2.97e-05	0.000335	CbGpPWpGaD
Mesalazine—CHUK—Immune System—RELA—Barrett's esophagus	2.51e-05	0.000284	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—RELA—Barrett's esophagus	2.28e-05	0.000257	CbGpPWpGaD
Mesalazine—CHUK—Disease—PTGS2—Barrett's esophagus	2.25e-05	0.000254	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—APC—Barrett's esophagus	2.08e-05	0.000235	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PTGS2—Barrett's esophagus	2.01e-05	0.000227	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—APC—Barrett's esophagus	1.88e-05	0.000213	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PPARG—Barrett's esophagus	1.79e-05	0.000202	CbGpPWpGaD
Mesalazine—PTGS2—Disease—APC—Barrett's esophagus	1.76e-05	0.000199	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—RELA—Barrett's esophagus	1.62e-05	0.000183	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CXCL8—Barrett's esophagus	1.53e-05	0.000173	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—RELA—Barrett's esophagus	1.47e-05	0.000166	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PPARG—Barrett's esophagus	1.42e-05	0.00016	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PTGS2—Barrett's esophagus	1.41e-05	0.000159	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CXCL8—Barrett's esophagus	1.39e-05	0.000157	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TP53—Barrett's esophagus	9.39e-06	0.000106	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TP53—Barrett's esophagus	8.51e-06	9.62e-05	CbGpPWpGaD
